Corrigendum to ‘Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia’ [J Infect 92 (2026)/106727]
Authors:
- 10 September 2026
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 93 (4) , 106851